Skip to main content
Search result for "Solr search content"
Search Result for "Breast Cancer"
Story

The role of genetic testing in cancer prevention and treatment

Discover how genetic testing at the Mays Cancer Center can guide cancer prevention and treatment. Learn about DNA analysis, personalized risk management, and family implications, as our expert counselors support your journey to proactive, informed cancer care.

Story

Meet the Mays Cancer Center's newest providers

We're thrilled to introduce four exceptional new doctors to our cancer center team! Their broad expertise and dedication make them ready to provide top-notch care and innovative treatments. Read to learn more about their impressive backgrounds and how they'll enhance our patient services. 

Clinical Trial

A Phase 1 Open-Label Study to Evaluate the Efficacy and Safety of ABBV-400 in Select Advanced Solid Tumor Indications

To assess the efficacy of ABBV-400 in each solid tumor indication, including advanced or metastatic hepatocellular (HCC), biliary tract cancer (BTC), pancreatic ductal adenocarcinoma (PDAC), esophageal squamous cell carcinoma (ESCC), triple negative (TN) breast cancer (BC), hormone receptor-positive (HR+)/human epidermal growth factor receptor 2 negative (HER2-) BC, and head and neck squamous cell carcinoma (HNSCC). The purpose of this study is to evaluate ABBV-400 in subjects with select solid tumors. This study will consist of multiple cohorts with each cohort investigating ABBV-400 at 3 mg/kg Q3W.

Cancer Treatment
Fertility Preservation

At Mays Cancer Center, home to UT Health San Antonio MD Anderson Cancer Center, our holistic approach includes fertility preservation services. You have access to highly skilled specialists and a wide range of options.